Literature DB >> 3409681

Simulation of linear compartment models with application to nuclear medicine kinetic modeling.

D Z D'Argenio1, A Schumitzky, W Wolf.   

Abstract

Several techniques are evaluated for solving the linear ordinary differential equations arising from compartment models. The methods involve approximating the matrix exponential of the state matrix (i.e. the transition matrix). The computational efficiencies of these techniques, together with that of a general purpose differential equation solver, are compared for several models arising from radiopharmacokinetic studies. The matrix exponential calculations are performed using both Ward's Padé approximation method and an eigenvalue-eigenvector decomposition (QR factorization) of the matrix A. These two algorithms have been incorporated as simulation options into the programs of the ADAPT package. ADAPT consists of a set of high-level programs for simulation, parameter estimation and experiment design, developed primarily for basic and clinical research modeling and data analysis applications involving pharmacokinetic and pharmacodynamic processes. The advantages and disadvantages of these simulation strategies for solving linear kinetic models within a parameter estimation setting are illustrated and discussed.

Mesh:

Substances:

Year:  1988        PMID: 3409681     DOI: 10.1016/0169-2607(88)90102-2

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  8 in total

1.  Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavir.

Authors:  T N Kakuda; L M Page; P L Anderson; K Henry; T W Schacker; F S Rhame; E P Acosta; R C Brundage; C V Fletcher
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  A combined specific target site binding and pharmacokinetic model to explore the non-linear disposition of draflazine.

Authors:  E Snoeck; P Jacqmin; A Van Peer; M Danhof
Journal:  J Pharmacokinet Biopharm       Date:  1999-06

3.  Pharmacokinetics of hyperimmune anti-human immunodeficiency virus immunoglobulin in persons with AIDS.

Authors:  C V Fletcher; B K Goodroad; L M Cummins; K Henry; H H Balfour; F S Rhame
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

4.  Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDS.

Authors:  H H Balfour; C V Fletcher; A Erice; W K Henry; E P Acosta; S A Smith; M A Holm; G Boivin; D H Shepp; C S Crumpacker; C A Eaton; S S Martin-Munley
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

5.  Oritavancin population pharmacokinetics in healthy subjects and patients with complicated skin and skin structure infections or bacteremia.

Authors:  Christopher M Rubino; Scott A Van Wart; Sujata M Bhavnani; Paul G Ambrose; Jill S McCollam; Alan Forrest
Journal:  Antimicrob Agents Chemother       Date:  2009-07-27       Impact factor: 5.191

6.  Strategies for control of zidovudine concentrations in serum.

Authors:  S E Noormohamed; W K Henry; F S Rhame; H H Balfour; C V Fletcher
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

7.  Foscarnet for suppression of human immunodeficiency virus replication.

Authors:  C V Fletcher; A C Collier; F S Rhame; D Bennett; M F Para; C C Beatty; C E Jones; H H Balfour
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

8.  A physiological model to evaluate drug kinetics in patients with hemorrhagic shock followed by fluid resuscitation. Application to amoxicillin-clavulanate.

Authors:  Michel Tod; Franck Lagneau; Vincent Jullien; Olivier Mimoz
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.